References
- Baluku JB, Nuwagira E, Bongomin F, Denning DW. Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities. Int J Tuberc Lung Dis. 2021;25(7):537–546. https://doi.org/10.5588/ijtld.21.0034
- Barker KR, Kus JV, Normand AC, Gharabaghi F, McTaggart L, Rotstein C, Richardson SE, Campigotto A, Tadros M. A Practical workflow for the identification of Aspergillus, Fusarium, Mucorales by MALDI-TOF MS: Database, medium, and incubation optimization. J Clin Microbiol. 2022;60(12):e0103222. https://doi. org/10.1128/jcm.01032-22
- Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G, Francalanci E, et al; PREDICO Study Group. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: A prospective study. Clin Infect Dis. 2021;73(11):e3606–e3614. https://doi.org/10.1093/cid/ciaa1065
- Chen D, Chen J. [Antifungal therapy for severe liver disease complicated with invasive fungal disease] (in Chinese). Chin Hepatol. 2021;26(7):804–807. https://doi.org/10.3969/j.iSSN.1008-1704.2021.07.025
- Chen M, Xu Y, Hong N, Yang Y, Lei W, Du L, Zhao J, Lei X, Xiong L, Cai L, et al. Epidemiology of fungal infections in China. Front Med. 2018;12(1):58–75. https://doi.org/10.1007/s11684-017-0601-0
- Coşkun AS, Durmaz ŞÖ. Fungal infections in COVID-19 intensive care patients. Pol J Microbiol. 2021;70(3):395–400. https://doi. org/10.33073/pjm-2021-039
- Ding L, Lu TT, Zhang YR, Feng ZY, Yin W, Guo J. [Epidemiological and drug resistance analysis of clinically isolated invasive Fungi in an area from 2019 to 2021] (in Chinese). Chin J Health Lab Technol. 2023;33(03):300–303.
- Fan G, Pan A, Huang Y, Li J, Yang J. [Pathogenic characteristics and drug resistance analysis of pulmonary infection in patients with pulmonary tuberculosis] (in Chinese). Chin Prev Med. 2020;21(03):316–319.
- George ME, Gaitor TT, Cluck DB, Henao-Martínez AF, Sells NR, Chastain DB. The impact of climate change on the epidemiology of fungal infections: Implications for diagnosis, treatment, and public health strategies. Ther Adv Infect Dis. 2025;12:20499361251313841. https://doi.org/10.1177/20499361251313841
- Giannella M, Lanternier F, Dellière S, Groll AH, Mueller NJ, Alastruey-Izquierdo A, Slavin MA; ECCMID study groups on Invasive Fungal Infection and Infection in Immunocompromised Hosts. Invasive fungal disease in the immunocompromised host: Changing epidemiology, new antifungal therapies, and management challenges. Clin Microbiol Infect. 2025;31(1):29–36. https://doi.org/10.1016/j.cmi.2024.08.006
- Guo Y, He HZ, Sun Z. [Clinical characteristics and risk factors of pulmonary tuberculosis associat-ed with pulmonary fungal infection] (in Chinese). Chin J Gerontol. 2019;39(02):294–297. https://doi.org/CNKI:SUN:ZLXZ.0.2019-02-016
- He XY, Ren Q, Xia YY. [The study of the pathogenic spectrum and epidemiologic features of invasive fungal infection in China during 2008-2017] (in Chinese). Chin J Mycol. 2018;13(4):229–234.
- Infection Group of the Respiratory Diseases Branch, Chinese Medical Association; Editorial Committee of the Chinese Journal of Tuberculosis and Respiratory Diseases. [Expert consensus on the diagnosis and treatment of pulmonary fungal diseases] (in Chinese). Chin J Tuberc Respir Dis. 2007;30:821–834. https://doi. org/10.3760/j.iSSN:1001-0939.2007.11.008
- Ji B, Lei YL, Xu LX, Lin Q, Zhou FX. [Prevalence of fungal infection in hospitalized patients with liver diseases and analysis of drug susceptibility] (in Chinese). Chin J Nosocomiol. 2017;27(05):1047– 1049+1057.
- Kou Y, Ji F, Fan L, Luo F. [Analysis of pathogenic characteristics and drug resistance of pulmonary tuberculosis complicated with pulmonary infection] (in Chinese). J Public Health Prev Med. 2019;30(04):121–123.
- Larone DH. Medically important fungi: A guide to identification. New York (USA), Amsterdam (The Netherlands), London(UK): Elsevier; 1987.
- Lass-Flörl C, Steixner S. The changing epidemiology of fungal infections. Mol Aspects Med. 2023;94:101215. https://doi. org/10.1016/j.mam.2023.101215
- Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: Review of literature. Chin Med J. 2013;126(2):361–368.
- Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017;17(11):e334–e343. https://doi. org/10.1016/s1473-3099(17)30303-1
- Liu C. [Analysis of clinical characteristics and influencing factors of pulmonary tuberculosis complicated by pulmonary fungal infection] (in Chinese). Chin J Clin Rarion Drug Use. 2020;13(18):142–144.
- Lou D, Zhan JH, Chen Q, Xu JQ, Yu Y. [Clinical distribution and drug resistance analysis of invasive fungal infections in a general hospital] (in Chinese). Pract Clin Med. 2023;24(02):95–99.
- Seagle EE, Williams SL, Chiller TM. Recent trends in the epidemiology of fungal infections. Infect Dis Clin North Am. 2021;35(2):237–260. https://doi.org/10.1016/j.idc.2021.03.001
- Tang J, Li Z, Ye F. [Influenza-associated pulmonary aspergillosis: epidemiology, diagnosis and treatment] (in Chinese). West China Med. J. 2020;35(01):1–4. https://doi.org/10.7507/1002-0179.202001079
- Vargas-Espíndola LA, Cuervo-Maldonado SI, Enciso-Olivera JL, Gómez-Rincón JC, Jiménez-Cetina L, Sánchez-Pedraza R, García-Guzmán K, López-Mora MJ, Álvarez-Moreno CA, Cortés JA, et al. Fungemia in hospitalized adult patients with hematological malignancies: Epidemiology and risk factors. J Fungi. 2023;9(4):400. https://doi.org/10.3390/jof9040400
- Versalovic J, Carroll,KC, Funke,G, Jorgensen JH, Landry ML, Warnock, DW. Manual of clinical microbiology. Washington (USA): ASM Press; 2011. https://doi.org/10.1128/9781555816728
- Wang X, Xiao Y, Cao X. [Risk factors and advances in prevention and control measures of invasive aspergillosis] (in Chinese). Chin J Infect Control. 2018;17(01):82–86.
- Wei L, Lu Z, Luo Y, Li L, Lu Y, Tang Y. [CT imaging characteristics of pulmonary tuberculosis patients complicated with fungal infection] (in Chinese). Chin J Nosocomiol. 2017;27(17):3921–3924.
- Xia J, Wang Z, Li T, Lu F, Sheng D, Huang W. Immunosuppressed patients with clinically diagnosed invasive fungal infections: The fungal species distribution, antifungal sensitivity and associated risk factors in a tertiary hospital of Anhui province. Infect Drug Resist. 2022;15:321–333. https://doi.org/10.2147/idr.s351260
- Xiao M, Sun ZY, Kang M, Guo DW, Liao K, Chen SC, Kong F, Fan X, Cheng JW, Hou X, et al.; China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group. Five-year national surveillance of invasive candidiasis: Species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018;56(7):e00577-00518 https://doi.org/10.1128/jcm.00577-18
- Xu H, Yu SY, Zhou ML, Ning YT, Xiao M, Li XG, Chen M, Kong F, Chen S, Ming L, et al. Epidemiology and antifungal susceptibility patterns of invasive fungal infections from 2012 to 2014 in a teaching hospital in central China. Infect Drug Resist. 2019;12:3641– 3651 https://doi.org/10.2147/idr.s227839
- Yang J, Shao D, Guo L, Liu J, Xu Y, Liang G. [Species distribution and antifungal susceptibility test of invasive Candida infection in a hospital in Beijing] (in Chinese). Chin J Mycol. 2020;15(06):359– 363+370.
- Yang Z, Yu J, Li R. [The epidemiology of invasive candidiasis in China] (in Chinese). Int J Epidemiol Infect Dis. 2021;48(4):266– 270.
- Zukiewicz-Sobczak WA. The role of fungi in allergic diseases. Postepy Dermatol Alergol. 2013;30(1):42–45. https://doi.org/10.5114/pdia.2013.33377